M&G Investment Management Ltd. Invests $15.45 Million in Agilent Technologies Inc (NYSE:A)

M&G Investment Management Ltd. acquired a new position in shares of Agilent Technologies Inc (NYSE:A) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 181,785 shares of the medical research company’s stock, valued at approximately $15,452,000.

Other large investors have also recently made changes to their positions in the company. FinTrust Capital Advisors LLC grew its holdings in shares of Agilent Technologies by 450.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 380 shares of the medical research company’s stock worth $32,000 after purchasing an additional 311 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Agilent Technologies by 185.5% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 471 shares of the medical research company’s stock worth $36,000 after purchasing an additional 306 shares during the period. NuWave Investment Management LLC grew its stake in shares of Agilent Technologies by 1,184.1% during the third quarter. NuWave Investment Management LLC now owns 565 shares of the medical research company’s stock worth $42,000 after purchasing an additional 521 shares during the period. Benjamin F. Edwards & Company Inc. grew its stake in shares of Agilent Technologies by 261.5% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 1,381 shares of the medical research company’s stock worth $106,000 after purchasing an additional 999 shares during the period. Finally, Duncker Streett & Co. Inc. acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $119,000.

NYSE:A opened at $87.18 on Wednesday. Agilent Technologies Inc has a 1 year low of $65.35 and a 1 year high of $90.64. The company has a current ratio of 1.53, a quick ratio of 1.21 and a debt-to-equity ratio of 0.38. The stock has a market cap of $27.38 billion, a price-to-earnings ratio of 25.95, a PEG ratio of 2.07 and a beta of 1.42. The stock has a 50-day moving average price of $86.28 and a two-hundred day moving average price of $77.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 25th. The medical research company reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.03. The company had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Agilent Technologies had a return on equity of 20.13% and a net margin of 20.74%. Agilent Technologies’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.81 earnings per share. Sell-side analysts forecast that Agilent Technologies Inc will post 3.41 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were given a dividend of $0.18 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.16. This represents a $0.72 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend was Monday, December 30th. Agilent Technologies’s dividend payout ratio is currently 23.15%.

A number of research analysts have issued reports on the company. Wells Fargo & Co assumed coverage on Agilent Technologies in a research note on Tuesday, January 7th. They issued an “overweight” rating and a $100.00 target price for the company. Stifel Nicolaus assumed coverage on Agilent Technologies in a research note on Thursday, November 14th. They issued a “hold” rating and a $85.00 target price for the company. Citigroup assumed coverage on Agilent Technologies in a research note on Monday, January 6th. They issued a “neutral” rating and a $85.00 target price for the company. UBS Group reissued a “buy” rating on shares of Agilent Technologies in a research note on Tuesday. Finally, Barclays decreased their target price on Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 9th. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Agilent Technologies currently has a consensus rating of “Buy” and an average target price of $84.57.

In other news, SVP Michael Tang sold 3,364 shares of the company’s stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $85.00, for a total transaction of $285,940.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Mark Doak sold 8,016 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $84.50, for a total value of $677,352.00. Following the transaction, the vice president now directly owns 142,017 shares of the company’s stock, valued at $12,000,436.50. The disclosure for this sale can be found here. Insiders have sold 89,685 shares of company stock valued at $7,470,816 over the last ninety days.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit